Medical - Healthcare Information Services
Compare Stocks
5 / 10Stock Comparison
NRC vs FORR vs MORN vs CSGP vs VRSK
Revenue, margins, valuation, and 5-year total return — side by side.
Consulting Services
Financial - Data & Stock Exchanges
Real Estate - Services
Consulting Services
NRC vs FORR vs MORN vs CSGP vs VRSK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Consulting Services | Financial - Data & Stock Exchanges | Real Estate - Services | Consulting Services |
| Market Cap | $440M | $135M | $6.92B | $13.65B | $22.93B |
| Revenue (TTM) | $139M | $392M | $2.45B | $3.41B | $3.10B |
| Net Income (TTM) | $9M | $-54M | $403M | $25M | $910M |
| Gross Margin | 55.9% | 54.0% | 61.0% | 77.4% | 67.4% |
| Operating Margin | 14.1% | -0.3% | 21.5% | -0.8% | 44.9% |
| Forward P/E | 22.2x | 9.2x | 15.3x | 23.6x | 22.9x |
| Total Debt | $79M | $72M | $1.41B | $1.14B | $5.04B |
| Cash & Equiv. | $4M | $63M | $475M | $1.73B | $2.18B |
NRC vs FORR vs MORN vs CSGP vs VRSK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | May 26 | Return |
|---|---|---|---|
| National Research C… (NRC) | 100 | 33.6 | -66.4% |
| Forrester Research,… (FORR) | 100 | 22.0 | -78.0% |
| Morningstar, Inc. (MORN) | 100 | 129.1 | +29.1% |
| CoStar Group, Inc. (CSGP) | 100 | 45.3 | -54.7% |
| Verisk Analytics, I… (VRSK) | 100 | 102.8 | +2.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NRC vs FORR vs MORN vs CSGP vs VRSK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NRC has the current edge in this matchup, primarily because of its strength in dividends and momentum.
- 2.5% yield, 1-year raise streak, vs MORN's 1.0%, (2 stocks pay no dividend)
- +45.9% vs CSGP's -56.5%
FORR ranks third and is worth considering specifically for value.
- Lower P/E (9.2x vs 22.9x)
MORN is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 12 yrs, beta 0.41, yield 1.0%
- Lower volatility, beta 0.41, current ratio 0.99x
- PEG 1.35 vs VRSK's 2.68
- Beta 0.41, yield 1.0%, current ratio 0.99x
CSGP is the clearest fit if your priority is growth exposure.
- Rev growth 18.7%, EPS growth -95.1%, 3Y rev CAGR 14.2%
- 18.7% FFO/revenue growth vs FORR's -8.2%
VRSK is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 132.6% 10Y total return vs MORN's 131.4%
- 29.3% margin vs FORR's -13.7%
- 16.7% ROA vs FORR's -13.0%, ROIC 33.0% vs 0.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.7% FFO/revenue growth vs FORR's -8.2% | |
| Value | Lower P/E (9.2x vs 22.9x) | |
| Quality / Margins | 29.3% margin vs FORR's -13.7% | |
| Stability / Safety | Beta 0.41 vs NRC's 0.80, lower leverage | |
| Dividends | 2.5% yield, 1-year raise streak, vs MORN's 1.0%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +45.9% vs CSGP's -56.5% | |
| Efficiency (ROA) | 16.7% ROA vs FORR's -13.0%, ROIC 33.0% vs 0.8% |
NRC vs FORR vs MORN vs CSGP vs VRSK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NRC vs FORR vs MORN vs CSGP vs VRSK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FORR leads in 1 of 6 categories
VRSK leads 1 • NRC leads 0 • MORN leads 0 • CSGP leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — CSGP and VRSK each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CSGP is the larger business by revenue, generating $3.4B annually — 24.6x NRC's $139M. VRSK is the more profitable business, keeping 29.3% of every revenue dollar as net income compared to FORR's -13.7%. On growth, CSGP holds the edge at +22.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $139M | $392M | $2.4B | $3.4B | $3.1B |
| EBITDAEarnings before interest/tax | $28M | $13M | $763M | $278M | $1.7B |
| Net IncomeAfter-tax profit | $9M | -$54M | $403M | $25M | $910M |
| Free Cash FlowCash after capex | $17M | -$8M | $437M | $241M | $1.1B |
| Gross MarginGross profit ÷ Revenue | +55.9% | +54.0% | +61.0% | +77.4% | +67.4% |
| Operating MarginEBIT ÷ Revenue | +14.1% | -0.3% | +21.5% | -0.8% | +44.9% |
| Net MarginNet income ÷ Revenue | +6.5% | -13.7% | +15.3% | +0.7% | +29.3% |
| FCF MarginFCF ÷ Revenue | +12.6% | -2.0% | +18.1% | +7.1% | +36.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.7% | -4.9% | — | +22.5% | +3.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -44.0% | +75.3% | +50.0% | +127.7% | +4.8% |
Valuation Metrics
FORR leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 20.5x trailing earnings, MORN trades at a 99% valuation discount to CSGP's 1939.8x P/E. Adjusting for growth (PEG ratio), MORN offers better value at 1.81x vs VRSK's 3.16x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $440M | $135M | $6.9B | $13.6B | $22.9B |
| Enterprise ValueMkt cap + debt − cash | $515M | $144M | $7.9B | $13.1B | $25.8B |
| Trailing P/EPrice ÷ TTM EPS | 37.56x | -1.12x | 20.52x | 1939.76x | 26.96x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.19x | 9.22x | 15.30x | 23.64x | 22.88x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.81x | — | 3.16x |
| EV / EBITDAEnterprise value multiple | 17.05x | 8.60x | 10.96x | 76.81x | 15.37x |
| Price / SalesMarket cap ÷ Revenue | 3.20x | 0.34x | 2.83x | 4.20x | 7.46x |
| Price / BookPrice ÷ Book value/share | 31.26x | 1.06x | 6.29x | 1.63x | 78.58x |
| Price / FCFMarket cap ÷ FCF | 27.96x | 7.47x | 15.64x | 332.86x | 19.24x |
Profitability & Efficiency
VRSK leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
VRSK delivers a 4.4% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $-39 for FORR. CSGP carries lower financial leverage with a 0.14x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRSK's 16.26x. On the Piotroski fundamental quality scale (0–9), MORN scores 6/9 vs FORR's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +57.2% | -39.2% | +30.0% | +0.3% | +4.4% |
| ROA (TTM)Return on assets | +6.6% | -13.0% | +10.9% | +0.2% | +16.7% |
| ROICReturn on invested capital | +18.8% | +0.8% | +15.3% | -0.9% | +33.0% |
| ROCEReturn on capital employed | +23.2% | +0.8% | +20.6% | -0.8% | +39.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 6 | 5 | 5 |
| Debt / EquityFinancial leverage | 5.65x | 0.57x | 1.15x | 0.14x | 16.26x |
| Net DebtTotal debt minus cash | $75M | $9M | $933M | -$589M | $2.9B |
| Cash & Equiv.Liquid assets | $4M | $63M | $475M | $1.7B | $2.2B |
| Total DebtShort + long-term debt | $79M | $72M | $1.4B | $1.1B | $5.0B |
| Interest CoverageEBIT ÷ Interest expense | 3.82x | 0.27x | 12.40x | 1.58x | 7.87x |
Total Returns (Dividends Reinvested)
Evenly matched — NRC and MORN and VRSK each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in VRSK five years ago would be worth $10,651 today (with dividends reinvested), compared to $1,629 for FORR. Over the past 12 months, NRC leads with a +45.9% total return vs CSGP's -56.5%. The 3-year compound annual growth rate (CAGR) favors MORN at -3.3% vs FORR's -37.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +9.2% | -13.5% | -13.0% | -51.0% | -20.6% |
| 1-Year ReturnPast 12 months | +45.9% | -34.2% | -40.5% | -56.5% | -43.7% |
| 3-Year ReturnCumulative with dividends | -49.7% | -75.9% | -9.6% | -59.1% | -17.7% |
| 5-Year ReturnCumulative with dividends | -52.0% | -83.7% | -18.1% | -62.3% | +6.5% |
| 10-Year ReturnCumulative with dividends | +91.8% | -75.1% | +131.4% | +55.9% | +132.6% |
| CAGR (3Y)Annualised 3-year return | -20.5% | -37.8% | -3.3% | -25.7% | -6.3% |
Risk & Volatility
Evenly matched — NRC and VRSK each lead in 1 of 2 comparable metrics.
Risk & Volatility
VRSK is the less volatile stock with a -0.13 beta — it tends to amplify market swings less than NRC's 0.80 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NRC currently trades 85.7% from its 52-week high vs CSGP's 33.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.80x | 0.57x | 0.41x | 0.61x | -0.13x |
| 52-Week HighHighest price in past year | $22.79 | $11.57 | $316.71 | $97.43 | $322.92 |
| 52-Week LowLowest price in past year | $11.01 | $4.88 | $149.08 | $31.36 | $156.00 |
| % of 52W HighCurrent price vs 52-week peak | +85.7% | +60.9% | +57.5% | +33.0% | +54.2% |
| RSI (14)Momentum oscillator 0–100 | 65.0 | 62.8 | 55.6 | 34.5 | 49.4 |
| Avg Volume (50D)Average daily shares traded | 89K | 86K | 487K | 6.6M | 1.8M |
Analyst Outlook
Evenly matched — NRC and MORN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FORR as "Hold", MORN as "Hold", CSGP as "Buy", VRSK as "Hold". Consensus price targets imply 90.0% upside for CSGP (target: $61) vs 29.9% for MORN (target: $237). For income investors, NRC offers the higher dividend yield at 2.51% vs MORN's 1.00%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | — | — | $236.50 | $61.18 | $231.25 |
| # AnalystsCovering analysts | — | 4 | 6 | 25 | 25 |
| Dividend YieldAnnual dividend ÷ price | +2.5% | — | +1.0% | — | +1.0% |
| Dividend StreakConsecutive years of raises | 1 | 6 | 12 | — | 7 |
| Dividend / ShareAnnual DPS | $0.49 | — | $1.82 | — | $1.81 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.6% | +1.9% | +11.4% | +4.2% | +2.7% |
FORR leads in 1 of 6 categories (Valuation Metrics). VRSK leads in 1 (Profitability & Efficiency). 4 tied.
NRC vs FORR vs MORN vs CSGP vs VRSK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NRC or FORR or MORN or CSGP or VRSK a better buy right now?
For growth investors, CoStar Group, Inc.
(CSGP) is the stronger pick with 18. 7% revenue growth year-over-year, versus -8. 2% for Forrester Research, Inc. (FORR). Morningstar, Inc. (MORN) offers the better valuation at 20. 5x trailing P/E (15. 3x forward), making it the more compelling value choice. Analysts rate CoStar Group, Inc. (CSGP) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NRC or FORR or MORN or CSGP or VRSK?
On trailing P/E, Morningstar, Inc.
(MORN) is the cheapest at 20. 5x versus CoStar Group, Inc. at 1939. 8x. On forward P/E, Forrester Research, Inc. is actually cheaper at 9. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Morningstar, Inc. wins at 1. 35x versus Verisk Analytics, Inc. 's 2. 68x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — NRC or FORR or MORN or CSGP or VRSK?
Over the past 5 years, Verisk Analytics, Inc.
(VRSK) delivered a total return of +6. 5%, compared to -83. 7% for Forrester Research, Inc. (FORR). Over 10 years, the gap is even starker: VRSK returned +132. 6% versus FORR's -75. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NRC or FORR or MORN or CSGP or VRSK?
By beta (market sensitivity over 5 years), Verisk Analytics, Inc.
(VRSK) is the lower-risk stock at -0. 13β versus National Research Corporation's 0. 80β — meaning NRC is approximately -720% more volatile than VRSK relative to the S&P 500. On balance sheet safety, CoStar Group, Inc. (CSGP) carries a lower debt/equity ratio of 14% versus 16% for Verisk Analytics, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NRC or FORR or MORN or CSGP or VRSK?
By revenue growth (latest reported year), CoStar Group, Inc.
(CSGP) is pulling ahead at 18. 7% versus -8. 2% for Forrester Research, Inc. (FORR). On earnings-per-share growth, the picture is similar: Morningstar, Inc. grew EPS 3. 4% year-over-year, compared to -1993. 3% for Forrester Research, Inc.. Over a 3-year CAGR, CSGP leads at 14. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NRC or FORR or MORN or CSGP or VRSK?
Verisk Analytics, Inc.
(VRSK) is the more profitable company, earning 29. 6% net margin versus -30. 1% for Forrester Research, Inc. — meaning it keeps 29. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VRSK leads at 44. 6% versus -2. 2% for CSGP. At the gross margin level — before operating expenses — CSGP leads at 75. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NRC or FORR or MORN or CSGP or VRSK more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Morningstar, Inc. (MORN) is the more undervalued stock at a PEG of 1. 35x versus Verisk Analytics, Inc. 's 2. 68x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Forrester Research, Inc. (FORR) trades at 9. 2x forward P/E versus 23. 6x for CoStar Group, Inc. — 14. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CSGP: 90. 0% to $61. 18.
08Which pays a better dividend — NRC or FORR or MORN or CSGP or VRSK?
In this comparison, NRC (2.
5% yield), VRSK (1. 0% yield), MORN (1. 0% yield) pay a dividend. FORR, CSGP do not pay a meaningful dividend and should not be held primarily for income.
09Is NRC or FORR or MORN or CSGP or VRSK better for a retirement portfolio?
For long-horizon retirement investors, Verisk Analytics, Inc.
(VRSK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 13), 1. 0% yield, +132. 6% 10Y return). Both have compounded well over 10 years (VRSK: +132. 6%, FORR: -75. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NRC and FORR and MORN and CSGP and VRSK?
These companies operate in different sectors (NRC (Healthcare) and FORR (Industrials) and MORN (Financial Services) and CSGP (Real Estate) and VRSK (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NRC is a small-cap quality compounder stock; FORR is a small-cap quality compounder stock; MORN is a small-cap quality compounder stock; CSGP is a mid-cap high-growth stock; VRSK is a mid-cap quality compounder stock. NRC, MORN, VRSK pay a dividend while FORR, CSGP do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.